Voloridge Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-274,875
Closed -$673K 1350
2025
Q2
$673K Buy
+274,875
New +$1.39M ﹤0.01% 1056
2023
Q4
Sell
-11,269
Closed -$231K 1413
2023
Q3
$231K Buy
+11,269
New +$205K ﹤0.01% 1310
2022
Q4
Sell
-184,455
Closed -$2.94M 1604
2022
Q3
$2.94M Sell
184,455
-52,012
-22% -$812K 0.02% 853
2022
Q2
$3.25M Buy
236,467
+18,360
+8% +$219K 0.02% 840
2022
Q1
$3.46M Buy
218,107
+163,736
+301% +$2.83M 0.02% 769
2021
Q4
$1.19M Buy
+54,371
New +$1.48M 0.01% 1230
2021
Q1
Sell
-45,448
Closed -$2.49M 1614
2020
Q4
$2.49M Buy
+45,448
New +$1.66M 0.02% 659
2020
Q2
Sell
-13,811
Closed -$193K 1458
2020
Q1
$193K Buy
+13,811
New +$273K 0.01% 964

Other funds holding RCKT